Clinical Trial Update: The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring whether empagliflozin may provide protective effects and potential efficacy in rheumatoid arthritis patients treated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis (RA), Methotrexate Induced Nephrotoxicity | Phase 4 | Status: NOT_YET_RECRUITING